Market overview
The global organ
transplantation market share, as per the study conducted by Market Research
Future (MRFR), is expected to reach at a compound annual growth rate of 9.5%
during the forecast period of 2023 to 2032.
Organ
transplantation involves the process of replacing the diseased and damaged
organ of an individual with a healthy organ. It is one of the great
advancements in the modern healthcare landscape. This medical procedure has
evolved and advanced over the years, thereby enhancing the clinical effectivity
of the same. Organs are donated by either some living donor or it is harvested
from the brain-dead organ donors. Dysfunction of the organ caused due to
diseases like cancer, severe injuries, failure of the organ, and due to genetic
disorders require the need for organ transplant procedures. Organs such as
heart, liver, lungs, kidney, and many more can be transplanted through this
procedure.
The
transplantation process is carried out primarily with the brain-dead patient
whose other organs are in a healthy state and can be used to save the life of
another person. An increasing number of organ transplantation surgeries
undertaken globally is one of the major drivers of the organ transplantation
market. Increasing prevalence of chronic diseases, advancements in technology,
changing lifestyle of individuals, and the rising aging population are some of
the other key factors influencing the growth of the global market.
Competitive Landscape
The global organ
transplantation market players of various notable players TransMedic, Inc.
(US), Transonic (US), Novartis International AG (Switzerland), OrganOX Limited
(UK), F. Hoffmann-La Roche Ltd. (Switzerland), Terumo Medical Corporation (US),
Preservation Solutions, Inc. (US), Transplant Biomedical (UK), Accord
Healthcare GmbH (Spain), Astellas Pharma, Inc (Japan), Pfizer, Inc. (US), Veloxis
Pharmaceuticals A/S (Denmark), Bio Med Pvt. Ltd. (US), GlaxoSmithKline Plc.
(UK), Sanofi (France), and others.
Market Segmentation
The global organ
transplantation market outlook segmentation is done as per the following
dynamics: type. End-users, products, and treatment.
By type, the
market comprises of lungs, heart, liver, kidney, and others.
By products, the
market segments into tissue products, organ preservation solutions, transplant
diagnostics, and others.
By type of
treatment, the market includes immunosuppressant, analgesic, and other. Immunosuppressant
is narrowed down into mTOR inhibitor, calcineurin inhibitors, steroids, antiproliferative
agents, and other. Whereas calcineurin inhibitors are divided into tacrolimus
and cyclosporine. And, mTOR inhibitor is broken down into sirolimus and
everolimus.
By type of
transplant, the market includes allograft, xenograft, autograft,
allotransplantation, xenotransplantation, and others.
By end users,
the market comprises transplant centers, hospitals, and others.
Regional Analysis
The regional
segmentation of the organ transplantation market insight covers the following
regions: Europe, Americas, Asia Pacific, and the Middle East and Africa.
America holds
the largest share of the market in the global standings of organ transplantation.
This is due to the increasing prevalence of chronic diseases. Other key factors
influencing the growth of the market in this region are the rising aging
population, an increase in the number of organ transplantation cases, and
striking developments in technology.
Europe stands
second in the global organ transplantation market due to various essential
factors or drivers. The regional market is driven by the developed
infrastructure, encouragement for the emergence of new organizations, and increasing
expenditures on healthcare.
Asia Pacific is
expected to grow at a notable pace in the near future and cement its position
as one of the key regions in the global organ transplantation market. Factors
such as fast-paced development in the healthcare industry, presence of a huge
patient population pool, and the availability of skilled professionals are the
major growth drivers of the market. However, in the Middle East and Africa
region, the poor economical condition coupled with the limited growth of the
healthcare sector is expected to be responsible for the meagre growth of the
region.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York 10013
United States of
America
No comments:
Post a Comment